Publications in collaboration with researchers from Universidad de La Frontera (3)

2019

  1. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 394, Núm. 10193, pp. 121-130

  2. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

    The Lancet, Vol. 394, Núm. 10193, pp. 131-138

2017

  1. Rivaroxaban with or without aspirin in stable cardiovascular disease

    New England Journal of Medicine, Vol. 377, Núm. 14, pp. 1319-1330